Mylan Drug Plant at Telangana Not Maintaining Standards: US FDA
The Mylan Laboratories Ltd's Unit 7 is deviating from the Current Good Manufacturing Practices(CGMP), warned the US Food and Drug Administration (FDA). The FDA, in its letter to Mylan, said that the company had not followed adequate cleaning measures and testing of raw materials for impurities; this could contaminate the materials that are used to produce medicines. The plant is located in the Sangareddy district of Telangana.